ARTICLE | Company News
Biogen, Schering-Plough infectious diseases news
March 27, 2000 8:00 AM UTC
BGEN said that an arbitration panel denied its claim, which entered arbitration in 1998, that SGP's Rebetron Combination Therapy for hepatitis C, consisting of Rebetol ribavirin and Intron A interfe...